Glow Blend

Glow Blend 50/10/10mg

A research peptide blend combining three synthetic peptides studied in cellular biology and tissue research literature. Each vial contains 50mg GHK-Cu, 10mg BPC-157, and 10mg TB-500 (70mg total peptide content).

Product Specifications

• Composition: 50mg GHK-Cu + 10mg BPC-157 + 10mg TB-500 (70mg total)
• Form: Lyophilized powder
• Vial Size: 70mg total in 3mL glass vial

About the Compounds

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper-binding tripeptide complex composed of glycine, histidine, and lysine bound to copper. GHK-Cu has been extensively studied in cellular research literature examining tissue biology, cellular signaling pathways, copper-binding peptide chemistry, and extracellular matrix research applications.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide composed of 15 amino acids, derived from a partial sequence of body protection compound originally isolated from human gastric juice. BPC-157 has been studied in cellular research literature examining tissue research pathways, angiogenic signaling, nitric oxide pathway interactions, and cellular biology applications.

TB-500 (Thymosin Beta-4 fragment) is a synthetic 17-amino acid peptide fragment representing the active actin-binding region of Thymosin Beta-4, a naturally occurring protein found in nearly all human and animal cells. TB-500 has been studied in research literature examining actin cytoskeletal dynamics, cellular migration, and angiogenesis pathway research.

Research Background

This blend is supplied for laboratories conducting comparative cellular research involving the three component peptides. The combined formulation allows researchers to study multiple peptides within a single sample preparation, streamlining laboratory workflows for parallel and comparative peptide research investigations.

Foundational research on each component compound is available through peer-reviewed scientific literature:

• GHK-Cu research — Foundational research by Pickart et al. on copper-binding peptide biology, available through PubMed (pubmed.ncbi.nlm.nih.gov)
• BPC-157 research — Foundational cellular biology research by Sikiric et al. at the University of Zagreb
• TB-500 / Thymosin Beta-4 research — Foundational research by Goldstein et al. on actin-binding peptide biology

Researchers seeking comprehensive literature reviews can access the full body of peer-reviewed research on each compound through PubMed and the National Institutes of Health’s PMC database (pmc.ncbi.nlm.nih.gov).